Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Chimerix Inc (NQ: CMRX )

0.9200 -0.0100 (-1.08%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Chimerix Inc

< Previous 1 2 3 4 5 Next >
4 Analysts Have This to Say About Chimerix
Via Benzinga
Chimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC201 Treatment of H3 K27M-Mutant Diffuse Midline Gliomas Published in "Cancer Discovery"
From Chimerix, Inc.
Via GlobeNewswire
CMRX Stock Warning! Smart Biotech Investors Will Avoid Chimerix Like the Plague.
CMRX stock may seem like a high-risk, high-potential play, but it makes sense why the market has bid down this biotech. 
Via InvestorPlace
Chimerix Reports Second Quarter 2023 Financial Results and Provides Operational Update
From Chimerix, Inc.
Via GlobeNewswire
7 Millionaire-Maker Penny Stocks to Buy Before the Window Closes
Although speculative trades are not for everyone, these millionaire-maker penny stocks could turn small bets into big returns. 
Via InvestorPlace
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Chimerix Earnings Preview
Via Benzinga
Looking Into Chimerix's Return On Capital Employed
Via Benzinga
Chimerix to Report Second Quarter 2023 Financial Results and Provide an Operational Update on August 3, 2023
From Chimerix, Inc.
Via GlobeNewswire
7 Small-Cap Stocks to Buy Before the Breakout
If you don’t mind the extreme risks involved, growth investors should target these ideas for best small cap stocks to buy. 
Via InvestorPlace
Why These 7 Stocks Are the Best Ways to Play Biotech Right Now
With biotech stocks offering myriad viable opportunities irrespective of broader conditions, this sector is worth a closer look. 
Via InvestorPlace
Chimerix Announces Promotion of Michael T. Andriole to President and Chief Executive Officer
From Chimerix, Inc.
Via GlobeNewswire
Chimerix's Earnings Outlook
Via Benzinga
7 Deeply Undervalued Growth Stocks to Buy in June
Investors may see significant rewards betting on these best undervalued growth stocks for June. 
Via InvestorPlace
Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference
From Chimerix, Inc.
Via GlobeNewswire
Chimerix to Participate in Cancer Moonshot Brain Cancers Forum on Glioblastoma (GBM) and Diffuse Intrinsic Pontine Glioma (DIPG) at White House
Forum Aim is to Share Progress and Spur Actions to Advance the Field 
From Chimerix, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
Via Benzinga
Chimerix Reports First Quarter 2023 Financial Results and Provides Operational Update
From Chimerix, Inc.
Via GlobeNewswire
Chimerix to Report First Quarter 2023 Financial Results and Provide an Operational Update on May 4, 2023
From Chimerix, Inc.
Via GlobeNewswire
Chimerix Announces Presentation of Multiple Imipridone Datasets at American Association for Cancer Research Annual Meeting
From Chimerix, Inc.
Via GlobeNewswire
7 Thrilling Biotech Stocks for Aggressive Investors to Buy
Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own. 
Via InvestorPlace
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the... 
Via Benzinga
Sunrun Down Over 10% On Silicon Valley Bank Exposure: What Other Companies Are Exposed?
Shares of Sunrun Inc (NASDAQ: RUN), the largest residential solar developer in the U.S, fell by as much as 15% on Friday as a result of the news that Silicon Valley Bank has been closed by the 
Via Benzinga
The Top 7 Growth Stocks in Biotech
The biotech sector always houses a great selection of growth stocks that can grow rapidly and reward investors over the long-term. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Chimerix Reports Fourth Quarter and Year End 2022 Financial Results and Provides Operational Update
From Chimerix, Inc.
Via GlobeNewswire
Chimerix to Present at Cowen and Company 43rd Annual Health Care Conference
From Chimerix, Inc.
Via GlobeNewswire
Chimerix to Report Fourth Quarter and Year End 2022 Financial Results and Provide an Operational Update on March 2, 2023
From Chimerix, Inc.
Via GlobeNewswire
7 Overlooked Value Stocks That Could Outperform the Market
For those investors seeking bargain opportunities with massive upside potential, these overlooked value stocks should fit the bill. 
Via InvestorPlace
The 7 Best Biotech Stocks to Buy for February 2023
Following the wave of red ink last year, astute investors should target the best biotech stocks to buy this month for strong growth potential. 
Via InvestorPlace
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.